Health Insurance Marketplace, Medicare, Medicaid, and Children's Health Insurance Programs; Additional Request for Nominations for the Advisory Panel on Outreach and Education (APOE), 23277-23279 [2015-09730]
Download as PDF
Federal Register / Vol. 80, No. 80 / Monday, April 27, 2015 / Notices
23277
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Rmajette on DSK2VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Projects (SIP) 15–007,
HPV Vaccine Impact among Men who
have Sex with Men (MSM), and, SIP 15–
009, Serosorting and Other Seroadaptive
Behaviors among Men who have Sex
with Men (MSM) in the US-designing a
Brief Survey Tool for Use in Clinical
Practice.
Time and Date: 10:00 a.m.–6:00 p.m.,
May 18, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘HPV Vaccine Impact among Men who
have Sex with Men (MSM), SIP 15–007,
and, Serosorting and Other Seroadaptive
Behaviors among Men who have Sex
with Men (MSM) in the US-designing a
Brief Survey Tool for Use in Clinical
Practice, SIP 15–009.’’
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Projects (SIP) 15–002,
Economic Impact of Clinical Trials
among Children Diagnosed with Cancer,
and, SIP 15–005, Economic Costs of
Quality Assurance in Lung Cancer
Screening Programs.
Time and Date: 11:00 a.m.–6:00 p.m.,
May 19, 2015.
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Economic Impact of Clinical Trials
among Children Diagnosed with Cancer,
SIP 15–002, and, Economic Costs of
Quality Assurance in Lung Cancer
Screening Programs, SIP 15–005.’’
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–09647 Filed 4–24–15; 8:45 am]
[FR Doc. 2015–09645 Filed 4–24–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Sep<11>2014
14:41 Apr 24, 2015
Jkt 235001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
[CMS–7036–N2]
Health Insurance Marketplace,
Medicare, Medicaid, and Children’s
Health Insurance Programs; Additional
Request for Nominations for the
Advisory Panel on Outreach and
Education (APOE)
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice requests
nominations for individuals to serve on
the Advisory Panel on Outreach and
Education (APOE).
DATES: Nominations will be considered
if we receive them at the appropriate
address, provided in the ‘‘ADDRESSES’’
section of this notice, no later than 5
p.m., Eastern Daylight Time (e.d.t.) on
May 18, 2015.
ADDRESSES: Mail or deliver nominations
to the following address: Abigail
Huffman, Designated Federal Official,
Office of Communications, CMS, 7500
Security Boulevard, Mail Stop S1–05–
06, Baltimore, MD 21244–1850 or email
nominations to Abigail.Huffman1@
cms.hhs.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Abigail Huffman, Designated Federal
Official, Office of Communications,
CMS, 7500 Security Boulevard, Mail
Stop S1–05–06, Baltimore, MD 21244,
410–786–0897, email,
Abigail.Huffman1@cms.hhs.gov or visit
the Web site at https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/APOE.html. Press inquiries are
handled through the CMS Press Office
at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel on Medicare
Education (the predecessor to the
APOE) was created in 1999 to advise
and make recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS), and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare education programs, including
with respect to the Medicare + Choice
(M + C) program added by the Balanced
Budget Act of 1997 (Pub. L. 105–33).
The Medicare Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
E:\FR\FM\27APN1.SGM
27APN1
Rmajette on DSK2VPTVN1PROD with NOTICES
23278
Federal Register / Vol. 80, No. 80 / Monday, April 27, 2015 / Notices
M + C program and renamed it the
Medicare Advantage (MA) program. We
have had substantial responsibilities to
provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. Successful
MA program implementation required
us to consider the views and policy
input from a variety of private sector
constituents and to develop a broad
range of public-private partnerships.
In addition, the Secretary, and by
delegation, the Administrator of CMS
were authorized under Title I of MMA
to establish the Medicare prescription
drug benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient
Protection and Affordable Care Act,
Pub. L. 111–148, and Health Care and
Education Reconciliation Act of 2010,
Pub. L. 111–152) expanded the
availability of other options for health
care coverage and enacted a number of
changes to Medicare as well as to
Medicaid and the Children’s Health
Insurance Program (CHIP). Qualified
individuals and qualified employers are
now able to purchase private health
insurance coverage through a
competitive marketplace, called the
Affordable Insurance Exchange (or
Health Insurance Marketplace, or
‘‘Marketplace’’). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
Marketplace. The APOE (the Panel)
allows us to consider a broad range of
views and information from interested
audiences in connection with this effort
and to identify opportunities to enhance
the effectiveness of education strategies
concerning the Affordable Care Act.
The APOE charter was originally
created in 1999, as the charter for the
Advisory Panel on Medicare Education.
The panel’s charter was renewed, and
the panel was renamed the Advisory
Panel for Outreach and Education, on
January 21, 2011. The charter was most
recently renewed on January 21, 2015.
VerDate Sep<11>2014
14:41 Apr 24, 2015
Jkt 235001
The APOE will advise HHS and CMS on
developing and implementing education
programs for individuals with, or who
are eligible for, the Health Insurance
Marketplace, Medicare, Medicaid, and
CHIP about options for selecting health
care coverage under these and other
programs intended to ensure improved
access to quality care, including
preventive services. The scope of this
panel, convened under the Federal
Advisory Committee Act (FACA), also
includes advising on education of
providers and stakeholders with respect
to the Affordable Care Act and certain
provisions of the Health Information
Technology for Economic and Clinical
Health (HITECH) Act enacted as part of
the American Recovery and
Reinvestment Act of 2009 (ARRA).
The charter will terminate on January
21, 2017, unless renewed by appropriate
action. The APOE was chartered under
42 U.S.C. 222 of the Public Health
Service Act, as amended. The APOE is
governed by the provisions of FACA
(Pub. L. 92–463), as amended (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of federal
advisory committees.
In accordance with the renewed
charter, the APOE will advise the
Secretary and the Administrator on
optimal strategies for the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP), or
coverage available through the Health
Insurance Marketplace.
• Enhancing the federal government’s
effectiveness in informing Health
Insurance Marketplace, Medicare,
Medicaid, and CHIP consumers, issuers,
providers, and stakeholders through
education and outreach programs of
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers, and
stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Health Insurance
Marketplace, Medicare, Medicaid, and
CHIP education programs.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Establishing links between outreach
and education, promoting consumer
understanding of health care coverage
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
choices, and facilitating consumer
selection/enrollment, which in turn
support the overarching goal of
improved access to quality care,
including preventive services,
envisioned under the Affordable Care
Act.
In the February 27, 2015 Federal
Register (80 FR 10688), we published a
notice titled ‘‘Health Insurance
Marketplace, Medicare, Medicaid, and
Children’s Health Insurance Programs;
Renewal of the Advisory Panel on
Outreach and Education (APOE) and
Request for Nominations’’. The notice
announced the renewal of the APOE
charter and requested nominations for
individuals to serve on the APOE.
II. Provisions of this Notice
This notice is an additional
solicitation of nominees for the Panel.
The APOE shall consist of no more than
20 members. The Chair shall either be
appointed from among the 20 members,
or a federal official will be designated to
serve as the Chair. The charter requires
that meetings shall be held
approximately four times per year.
Members will be expected to attend all
meetings. The members and the Chair
shall be selected from authorities
knowledgeable in one or more of the
following fields:
• Senior citizen advocacy
• Outreach to minority and
underserved communities
• Health communications
• Disease-related advocacy
• Disability policy and access
• Health economics research
• Behavioral health
• Health insurers and plans
• Health information technology (IT)
• Social media
• Direct patient care
• Matters of labor and retirement
Representatives of the general public
may also serve on the APOE.
This notice announces that, in July
2015, the terms of 11 existing members
will expire, and in October 2015, the
terms of 2 additional members will
expire. This notice invites interested
organizations or individuals to submit
nominations for membership for all 13
upcoming vacancies on the APOE (no
self-nominations will be accepted). The
Secretary, or designee, will appoint new
members to the APOE from among those
candidates determined to have the
expertise required to meet specific
agency needs, in a manner to ensure an
appropriate balance of membership. We
are committed to ensuring that the
interests of both women and men,
members of all racial and ethnic groups,
and disabled individuals are adequately
E:\FR\FM\27APN1.SGM
27APN1
Federal Register / Vol. 80, No. 80 / Monday, April 27, 2015 / Notices
represented on the APOE. Therefore, we
encourage nominations of qualified
candidates who can represent these
interests. Any interested organization or
person may nominate one or more
qualified persons.
Each nomination must include a letter
stating that the nominee has expressed
a willingness to serve as a Panel
member and must be accompanied by a
curricula vitae and a brief biographical
summary of the nominee’s experience.
While we are looking for experts in a
number of fields, our most critical needs
are for experts in Health IT, Tribal
Affairs, Community Health Centers/
Medically Underserved Populations,
African-American Health/Disparities,
Health/Disability, Quality/Disparities,
and State Programs/Medicaid/Rural.
We are requesting that all curricula
vitae include the following:
• Date of birth
• Place of birth
• Title and current position
• Professional affiliation
• Home and business address
• Telephone and fax numbers
• Email address
• List of areas of expertise
Phone interviews of nominees may also
be requested after review of the
nominations.
In order to permit an evaluation of
possible sources of conflict of interest,
potential candidates will be asked to
provide detailed information concerning
such matters as financial holdings,
consultancies, and research grants or
contracts.
Members are invited to serve for 2year terms, contingent upon the renewal
of the APOE by appropriate action prior
to its termination. A member may serve
after the expiration of his or her term
until a successor takes office. Any
member appointed to fill a vacancy for
an unexpired term shall be appointed
for the remainder of that term.
Rmajette on DSK2VPTVN1PROD with NOTICES
III. Copies of the Charter
The Secretary’s Charter for the APOE
is available on the CMS Web site at:
https://www.cms.gov/RegulationsandGuidance/Guidance/FACA/
APOE.html, or you may obtain a copy of
the charter by submitting a request to
the contact listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Authority: Sec. 222 of the Public Health
Service Act (42 U.S.C. 217a) and sec. 10(a)
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102–3).
VerDate Sep<11>2014
14:41 Apr 24, 2015
Jkt 235001
Dated: April 21, 2015.
Andrew M. Slavitt
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2015–09730 Filed 4–24–15; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–D–1309]
M8 Electronic Common Technical
Document v4.0 Draft Implementation
Guide v2.0; Electronic Common
Technical Document v4.0
Implementation Package Draft
Specification for Submission Formats
v2.0; International Conference on
Harmonisation; Draft Guidance for
Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance entitled ‘‘M8 Electronic
Common Technical Document (eCTD)
v4.0 Draft Implementation Guide v2.0’’
(the M8 eCTD draft implementation
guidance) and a related document
entitled ‘‘eCTD v4.0 Implementation
Package Draft Specification for
Submission Formats v2.0’’ (the draft
specifications document). The M8 eCTD
draft implementation guidance and the
draft specifications document were
prepared under the auspices of the
International Conference on
Harmonisation (ICH) of Technical
Requirements for Registration of
Pharmaceuticals for Human Use. The
M8 eCTD draft implementation
guidance provides instructions for
creating the eCTD v4.0 Health Level 7
Regulated Product Submission (RPS)
message for Modules 2 through 5 of the
eCTD. The draft specifications
document provides specifications for
creating files for inclusion in the eCTD.
These draft documents represent major
updates to the eCTD specifications.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115 (g)(5)), to ensure that the Agency
considers your comment on these draft
documents before it begins work on the
final versions of the documents, submit
either electronic or written comments
on the draft documents by May 27,
2015.
SUMMARY:
Submit written requests for
single copies of the draft documents to
ADDRESSES:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
23279
the Division of Drug Information (HFD–
240), Center for Drug Evaluation and
Research (CDER), Food and Drug
Administration, 10001 New Hampshire
Ave., Hillandale Building, 4th Floor,
Silver Spring, MD 20993–0002; or the
Office of Communication, Outreach and
Development, Center for Biologics
Evaluation and Research (CBER), Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, rm. 3128,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist the office in processing your
requests. The draft documents may also
be obtained by mail by calling CBER at
1–800–835–4709 or 240–402–7800. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance documents.
Submit electronic comments on the
draft documents to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Regarding the guidance: Jared Lantzy,
Center for Drug Evaluation and
Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 22, Rm. 1116, Silver Spring,
MD 20993–0002, 301–796–0597; or
Mark Gray, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7217,
Silver Spring, MD 20993–0002, 301–
796–2081.
Regarding the ICH: Michelle Limoli,
Center for Drug Evaluation and
Research, International Programs, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 1174,
Silver Spring, MD 20993–0002, 301–
796–8377.
SUPPLEMENTARY INFORMATION:
I. Background
In recent years, many important
initiatives have been undertaken by
regulatory authorities and industry
associations to promote international
harmonization of regulatory
requirements. FDA has participated in
many meetings designed to enhance
harmonization and is committed to
seeking scientifically based harmonized
technical procedures for pharmaceutical
development. One of the goals of
harmonization is to identify and then
reduce differences in technical
requirements for drug development
among regulatory agencies.
ICH was organized to provide an
opportunity for tripartite harmonization
initiatives to be developed with input
E:\FR\FM\27APN1.SGM
27APN1
Agencies
[Federal Register Volume 80, Number 80 (Monday, April 27, 2015)]
[Notices]
[Pages 23277-23279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09730]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7036-N2]
Health Insurance Marketplace, Medicare, Medicaid, and Children's
Health Insurance Programs; Additional Request for Nominations for the
Advisory Panel on Outreach and Education (APOE)
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice requests nominations for individuals to serve on
the Advisory Panel on Outreach and Education (APOE).
DATES: Nominations will be considered if we receive them at the
appropriate address, provided in the ``ADDRESSES'' section of this
notice, no later than 5 p.m., Eastern Daylight Time (e.d.t.) on May 18,
2015.
ADDRESSES: Mail or deliver nominations to the following address:
Abigail Huffman, Designated Federal Official, Office of Communications,
CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244-
1850 or email nominations to Abigail.Huffman1@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail
Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email,
Abigail.Huffman1@cms.hhs.gov or visit the Web site at https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press
inquiries are handled through the CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel on Medicare Education (the predecessor to the
APOE) was created in 1999 to advise and make recommendations to the
Secretary of the U.S. Department of Health and Human Services (HHS),
and the Administrator of the Centers for Medicare & Medicaid Services
(CMS) on the effective implementation of national Medicare education
programs, including with respect to the Medicare + Choice (M + C)
program added by the Balanced Budget Act of 1997 (Pub. L. 105-33).
The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173)
expanded the existing health plan options and benefits available under
the
[[Page 23278]]
M + C program and renamed it the Medicare Advantage (MA) program. We
have had substantial responsibilities to provide information to
Medicare beneficiaries about the range of health plan options available
and better tools to evaluate these options. Successful MA program
implementation required us to consider the views and policy input from
a variety of private sector constituents and to develop a broad range
of public-private partnerships.
In addition, the Secretary, and by delegation, the Administrator of
CMS were authorized under Title I of MMA to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient Protection and Affordable Care
Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act
of 2010, Pub. L. 111-152) expanded the availability of other options
for health care coverage and enacted a number of changes to Medicare as
well as to Medicaid and the Children's Health Insurance Program (CHIP).
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through a competitive marketplace,
called the Affordable Insurance Exchange (or Health Insurance
Marketplace, or ``Marketplace''). In order to effectively implement and
administer these changes, we must provide information to consumers,
providers, and other stakeholders through education and outreach
programs regarding how existing programs will change and the expanded
range of health coverage options available, including private health
insurance coverage through the Marketplace. The APOE (the Panel) allows
us to consider a broad range of views and information from interested
audiences in connection with this effort and to identify opportunities
to enhance the effectiveness of education strategies concerning the
Affordable Care Act.
The APOE charter was originally created in 1999, as the charter for
the Advisory Panel on Medicare Education. The panel's charter was
renewed, and the panel was renamed the Advisory Panel for Outreach and
Education, on January 21, 2011. The charter was most recently renewed
on January 21, 2015. The APOE will advise HHS and CMS on developing and
implementing education programs for individuals with, or who are
eligible for, the Health Insurance Marketplace, Medicare, Medicaid, and
CHIP about options for selecting health care coverage under these and
other programs intended to ensure improved access to quality care,
including preventive services. The scope of this panel, convened under
the Federal Advisory Committee Act (FACA), also includes advising on
education of providers and stakeholders with respect to the Affordable
Care Act and certain provisions of the Health Information Technology
for Economic and Clinical Health (HITECH) Act enacted as part of the
American Recovery and Reinvestment Act of 2009 (ARRA).
The charter will terminate on January 21, 2017, unless renewed by
appropriate action. The APOE was chartered under 42 U.S.C. 222 of the
Public Health Service Act, as amended. The APOE is governed by the
provisions of FACA (Pub. L. 92-463), as amended (5 U.S.C. Appendix 2),
which sets forth standards for the formation and use of federal
advisory committees.
In accordance with the renewed charter, the APOE will advise the
Secretary and the Administrator on optimal strategies for the
following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, and the Children's Health Insurance Program (CHIP), or
coverage available through the Health Insurance Marketplace.
Enhancing the federal government's effectiveness in
informing Health Insurance Marketplace, Medicare, Medicaid, and CHIP
consumers, issuers, providers, and stakeholders through education and
outreach programs of issues regarding these programs, including the
appropriate use of public-private partnerships to leverage the
resources of the private sector in educating beneficiaries, providers,
and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Health Insurance Marketplace, Medicare, Medicaid, and CHIP education
programs.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Establishing links between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
preventive services, envisioned under the Affordable Care Act.
In the February 27, 2015 Federal Register (80 FR 10688), we
published a notice titled ``Health Insurance Marketplace, Medicare,
Medicaid, and Children's Health Insurance Programs; Renewal of the
Advisory Panel on Outreach and Education (APOE) and Request for
Nominations''. The notice announced the renewal of the APOE charter and
requested nominations for individuals to serve on the APOE.
II. Provisions of this Notice
This notice is an additional solicitation of nominees for the
Panel. The APOE shall consist of no more than 20 members. The Chair
shall either be appointed from among the 20 members, or a federal
official will be designated to serve as the Chair. The charter requires
that meetings shall be held approximately four times per year. Members
will be expected to attend all meetings. The members and the Chair
shall be selected from authorities knowledgeable in one or more of the
following fields:
Senior citizen advocacy
Outreach to minority and underserved communities
Health communications
Disease-related advocacy
Disability policy and access
Health economics research
Behavioral health
Health insurers and plans
Health information technology (IT)
Social media
Direct patient care
Matters of labor and retirement
Representatives of the general public may also serve on the APOE.
This notice announces that, in July 2015, the terms of 11 existing
members will expire, and in October 2015, the terms of 2 additional
members will expire. This notice invites interested organizations or
individuals to submit nominations for membership for all 13 upcoming
vacancies on the APOE (no self-nominations will be accepted). The
Secretary, or designee, will appoint new members to the APOE from among
those candidates determined to have the expertise required to meet
specific agency needs, in a manner to ensure an appropriate balance of
membership. We are committed to ensuring that the interests of both
women and men, members of all racial and ethnic groups, and disabled
individuals are adequately
[[Page 23279]]
represented on the APOE. Therefore, we encourage nominations of
qualified candidates who can represent these interests. Any interested
organization or person may nominate one or more qualified persons.
Each nomination must include a letter stating that the nominee has
expressed a willingness to serve as a Panel member and must be
accompanied by a curricula vitae and a brief biographical summary of
the nominee's experience.
While we are looking for experts in a number of fields, our most
critical needs are for experts in Health IT, Tribal Affairs, Community
Health Centers/Medically Underserved Populations, African-American
Health/Disparities, Health/Disability, Quality/Disparities, and State
Programs/Medicaid/Rural.
We are requesting that all curricula vitae include the following:
Date of birth
Place of birth
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
Email address
List of areas of expertise
Phone interviews of nominees may also be requested after review of the
nominations.
In order to permit an evaluation of possible sources of conflict of
interest, potential candidates will be asked to provide detailed
information concerning such matters as financial holdings,
consultancies, and research grants or contracts.
Members are invited to serve for 2-year terms, contingent upon the
renewal of the APOE by appropriate action prior to its termination. A
member may serve after the expiration of his or her term until a
successor takes office. Any member appointed to fill a vacancy for an
unexpired term shall be appointed for the remainder of that term.
III. Copies of the Charter
The Secretary's Charter for the APOE is available on the CMS Web
site at: https://www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html, or you may obtain a copy of the charter by submitting a
request to the contact listed in the FOR FURTHER INFORMATION CONTACT
section of this notice.
Authority: Sec. 222 of the Public Health Service Act (42 U.S.C.
217a) and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102-3).
Dated: April 21, 2015.
Andrew M. Slavitt
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2015-09730 Filed 4-24-15; 8:45 am]
BILLING CODE 4120-01-P